角膜移植中的免疫豁免
角膜移植是人类最成功的实体器官移植,其 extraordinary 成功与「免疫豁免」现象有关。本文综述了角膜移植免疫豁免的三大机制:角膜的解剖、细胞和分子屏障;与前房相关免疫偏离及调节性 T 细胞相关的耐受;以及免疫抑制性眼内微环境,并讨论了恢复免疫豁免的治疗策略。
要点
- 角膜移植是人类最成功的实体器官移植。
- 角膜移植免疫豁免涉及角膜屏障、前房相关免疫偏离与调节性 T 细胞耐受、免疫抑制性眼内微环境三大机制。
- 本文综述来自眼部炎症动物模型(尤其角膜移植模型)的免疫豁免机制及其临床相关性,并讨论恢复免疫豁免的治疗策略。
核心结论
- 角膜移植的 extraordinary 成功与「免疫豁免」现象有关。
- 目前认为三大机制为角膜移植提供免疫豁免:角膜的解剖、细胞和分子屏障;与前房相关免疫偏离及调节性 T 细胞相关的耐受;免疫抑制性眼内微环境。
研究设计与样本
- 综述,描述从眼部炎症动物模型(尤其涉及角膜移植的模型)中阐明的免疫豁免机制及其临床相关性。
主要发现
- 角膜移植是人类最成功的实体器官移植。
- 眼具有免疫豁免,炎症受自我调节以维持眼部功能。
- 目前认为三大机制为角膜移植提供免疫豁免:角膜的解剖、细胞和分子屏障;与前房相关免疫偏离及调节性 T 细胞相关的耐受;免疫抑制性眼内微环境。
- 本文提供局部和全身免疫调节中分子、细胞和神经相互作用的最新进展,并讨论恢复免疫豁免的治疗策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Corneal transplantation is the most successful solid organ transplantation performed in humans. The extraordinary success of orthotopic corneal allografts, in both humans and experimental animals, is related to the phenomenon of "immune privilege". Inflammation is self-regulated to preserve ocular functions because the eye has immune privilege. At present, three major mechanisms are considered to provide immune privilege in corneal transplantation: 1) anatomical, cellular, and molecular barriers in the cornea; 2) tolerance related to anterior chamber-associated immune deviation and regulatory T cells; and 3) an immunosuppressive intraocular microenvironment. This review describes the mechanisms of immune privilege that have been elucidated from animal models of ocular inflammation, especially those involving corneal transplantation, and its relevance for the clinic. An update on molecular, cellular, and neural interactions in local and systemic immune regulation is provided. Therapeutic strategies for restoring immune privilege are also discussed.
引用
- Hori J, Yamaguchi T, Keino H, et al. Immune privilege in corneal transplantation. Prog Retin Eye Res. 2019. PMID: 31014973. doi:10.1016/j.preteyeres.2019.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。